A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects-Reference-Cited by-同舟云学术

A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects

Published:2019-11-25 Issue:1 Volume:40 Page:16-29
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharmacol Rep

Author:

Ermer James¹,Martin Patrick²^ORCID,Corcoran Mary²,Matsuo Yumiko³

Affiliation:

1. Shire Wayne PA USA

2. Shire Lexington MA USA

3. Shionogi & Co., Ltd Osaka Japan

Funder

Shire

Shionogi

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12082

Reference33 articles.

1. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers

2. Shire.Elvanse® (lisdexamfetamine dimesylate);2018. [Cited 11 October 2018]. Available fromhttps://www.shire.com/products/product-list

3. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

4. Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study

5. Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review;Human Psychopharmacology: Clinical and Experimental;2024-07-18

2. An Efficient Combination Therapy with Lisdexamfetamine Dimesylate and Topiramate in Improving Binge Eating Scale & Metabolic Profile in Binge Eating Disorder: A Randomized Control Trial;Clinical Psychopharmacology and Neuroscience;2024-06-27

3. Stability of Lisdexamfetamine in Sampled Whole Blood—Implications of Sampling Tube Additives and Storage Temperature for Interpretation of Impairment;Journal of Analytical Toxicology;2022-05-03

4. Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects;British Journal of Clinical Pharmacology;2020-12-09

5. Population pharmacokinetic and exposure-response analyses of d-amphetamine after administration of lisdexamfetamine dimesylate in Japanese pediatric ADHD patients;Drug Metabolism and Pharmacokinetics;2020-12